Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Simulations Plus Inc (NQ: SLP )

38.92 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EST, Dec 5, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Simulations Plus Inc

< Previous 1 2 3 4 5 6 Next >
Simulations Plus Reports Fourth Quarter and Full Year Fiscal 2021 Results
From Simulations Plus, Inc.
Via Business Wire
Earnings Scheduled For October 25, 2021
Companies Reporting Before The Bell • HNI (NYSE:HNI) is expected to report quarterly earnings at $0.43 per share on revenue of $592.14 million. • Travelzoo (... 
Via Benzinga
Analyzing Simulations Plus's Ex-Dividend Date
On July 12, 2021, Simulations Plus (NASDAQ:SLP) declared a... 
Via Benzinga
Simulations Plus Announces the University+ Program
From Simulations Plus, Inc.
Via Business Wire
Bet On Biopharma: Data, Digitization, Discovery
The after-effects of pandemic-era policies will be with us for some time — with many supply chains still experiencing significant disruption. The worst of this “scarring” will heal. But the... 
Via Talk Markets
Simulations Plus Announces Cash Dividend
From Simulations Plus, Inc.
Via Business Wire
Simulations Plus Sets Date for 4th Quarter and Fiscal Year 2021 Earnings Release and Conference Call
From Simulations Plus, Inc.
Via Business Wire
12 Health Care Stocks Moving In Wednesday's After-Market Session
Gainers Regencell Bioscience (NASDAQ:RGC)... 
Via Benzinga
Simulations Plus Releases ADMET Predictor® (X.3)
From Simulations Plus, Inc.
Via Business Wire
Simulations Plus Receives New Grant Award From the FDA
From Simulations Plus, Inc.
Via Business Wire
Simulations Plus to Participate in BofA Securities and Oppenheimer Investor Conferences
From Simulations Plus, Inc.
Via Business Wire
Simulations Plus Reports Continued Success in Second Phase of AIDD Collaboration with Large Pharmaceutical Company
From Simulations Plus, Inc.
Via Business Wire
NMPA’s Center for Drug Evaluation Adds Licenses of GastroPlus®
From Simulations Plus, Inc.
Via Business Wire
Return on Capital Employed Overview: Simulations Plus
Pulled from Benzinga Pro data Simulations Plus (NASDAQ:SLP) posted Q3 earnings of $4.42 million, an increase from Q2 of 31.42%. Sales dropped to $12.78 million, a 2.81% decrease... 
Via Benzinga
Looking into Simulations Plus's Return on Capital Employed
Pulled from Benzinga Pro data Simulations Plus (NASDAQ:SLP) posted Q3 earnings of $4.42 million, an increase from Q2 of 31.42%. Sales dropped to $12.78 million, a 2.81% decrease... 
Via Benzinga
Stocks That Hit 52-Week Lows On Monday
Stocks That Hit 52-Week Lows On Monday Monday morning, 285 companies reached new 52-week lows. Noteworthy Points: The largest company by market cap to set a new 52-week... 
Via Benzinga
Stocks That Hit 52-Week Lows On Wednesday
Wednesday morning saw 57 companies set new 52-week lows. Noteworthy Points: Campbell Soup (NYSE:CPB) was the largest firm by market cap to set a new 52-week low.... 
Via Benzinga
Simulations Plus Target Price Lowered At Craig-Hallum, Raymond James After Q3 Sales Miss Expectations
Craig-Hallum analyst Matt Hewitt lowered the Simulations Plus Inc (NASDAQ: SLP) price target to $65 from $74 and kept a Hold rating on the stock. Unfortunately,... 
Via Benzinga
Topics Earnings
Exposures Financial
Here's Why Simulations Plus Stock Is Sliding Today
Investors weren't happy about hiccups that pressured fiscal third-quarter revenue. 
Via The Motley Fool
64 Biggest Movers From Yesterday
Gainers Allied Healthcare Products, Inc. (NASDAQ: AHPI) shares climbed 128.8% to settle at $9.06 on Tuesday. Red Cat Holdings, Inc. (NASDAQ: RCAT) surged 60.3% to settle at $4.76... 
Via Benzinga
Stocks That Hit 52-Week Lows On Tuesday
Before 10 a.m. ET on Tuesday, 48 companies set new 52-week lows. Interesting Highlights: Marqeta (NASDAQ:MQ) was the largest company by market cap to set a new 52-... 
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Gainers SCWorx (NASDAQ:WORX) stock increased by 38.34% to $3.68 during Tuesday's pre-market session. The company's market cap stands at $36.9 million. PLx Pharma (... 
Via Benzinga
Simulations Plus, inc (SLP) Q3 2021 Earnings Call Transcript
SLP earnings call for the period ending May 31, 2021. 
Via The Motley Fool
Topics Earnings
Exposures Financial
12 Health Care Stocks Moving In Monday's After-Market Session
Gainers SCWorx (NASDAQ:WORX) shares rose... 
Via Benzinga
Simulations Plus: Q3 Earnings Insights
Shares of Simulations Plus (NASDAQ:SLP) rose fell in after-market trading after the company reported Q3 results. Quarterly Results Earnings per share fell 10.00% year over year to... 
Via Benzinga
Simulations Plus Reports Third Quarter Fiscal 2021 Financial Results
From Simulations Plus, Inc.
Via Business Wire
A Peek Into The Markets: US Stock Futures Mostly Lower; Crude Oil Down
Pre-open movers U.S. stock futures traded mostly lower in early pre-market trade after the Dow Jones jumped around 450 points on Friday. Investors are awaiting earnings results... 
Via Benzinga
Topics Stocks
Exposures Fossil Fuels US Equities
5 Stocks To Watch For July 12, 2021
Some of the stocks that may grab investor focus today are: Wall Street expects Simulations Plus Inc (NASDAQ: SLP) to report quarterly earnings at $0.18 per share on revenue of $... 
Via Benzinga
Earnings Scheduled For July 12, 2021
Companies Reporting After The Bell • VOXX International (NASDAQ:VOXX) is projected to report quarterly loss at $0.25 per share on revenue of $125.00 million. •... 
Via Benzinga
Simulations Plus Earnings Preview
On Monday, July 12, Simulations Plus (NASDAQ:SLP) will release its latest earnings report. Decipher the announcement with Benzinga's help. Net Income, Earnings, And Earnings Per... 
Via Benzinga
< Previous 1 2 3 4 5 6 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.